Bucking trends.
Backed by experience. 

We’re developing therapies to reverse the debilitating consequences of damage and disease of the brain and spinal cord to restore independence and improve lives.

Leadership

  • Travis Stiles, PhD

    CEO & Co-founder

  • David Weiner, MD

    Executive Chairman

  • William Hoekstra, PhD

    Drug Discovery & Development

  • Lynne Mayman, MS, PMP

    Project Management

  • Sarah Busch, PhD

    Non-Clinical Translation

  • Ryan McMillian, MBA

    CFO & Financial Strategy

  • Shawn Gahr, MIA

    Shawn Gahr, MIA

    COO & Co-founder

Scientific Advisory Board

  • Lawrence Goldstein, PhD

  • Jennifer Rauch, PhD

    Jennifer Rauch, PhD

  • Kurt Brunden, PhD

    Kurt Brunden, PhD

  • James Whisstock, PhD

    James Whisstock, PhD

  • Rivka Kreitman, PhD

    Rivka Kreitman, PhD

  • Miguel de los Rios, PhD

    Miguel de los Rios, PhD

Spinal Cord Injury Advisory Council

  • Michael G. Fehlings

    Michael G. Fehlings, MD, PhD

  • Linda Jones, PT, Ph.D.

  • Bryn Martin

    Bryn Martin, PhD

  • Robert Eastlack, MD

Board of Directors

  • Travis Stiles, PhD

    Travis Stiles, PhD

    Chairman of the Board

  • David Weiner, MD

    Board Member

  • Mike Goguen

    Board Member

  • Shawn Gahr

    Shawn Gahr

    Board Member